{
  "trial_id": "NCT01001104",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, body mass index (BMI), duration of diabetes, baseline HbA1c, weight, fasting plasma glucose, blood pressure, lipid profile, renal function, liver function, prior antidiabetic medication use, smoking status, alcohol consumption, physical activity level.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Percentage of Glycosylated Hemoglobin (HbA1c)",
          "baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Fasting Blood Glucose (FBG)"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of diabetes",
        "weight",
        "fasting plasma glucose",
        "blood pressure",
        "lipid profile",
        "renal function",
        "liver function",
        "prior antidiabetic medication use",
        "smoking status",
        "alcohol consumption",
        "physical activity level"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Blood Pressure, Fasting Plasma Glucose, Use of Oral Antidiabetic Drugs,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Percentage of Glycosylated Hemoglobin (HbA1c)",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Fasting Blood Glucose (FBG)"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Duration of Diabetes",
        "Blood Pressure",
        "Fasting Plasma Glucose",
        "Use of Oral Antidiabetic Drugs"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Duration of Diabetes, HbA1c, Fasting Plasma Glucose, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, HDL Cholesterol, LDL Cholesterol.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Percentage of Glycosylated Hemoglobin (HbA1c)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Fasting Blood Glucose (FBG)"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Duration of Diabetes",
        "Fasting Plasma Glucose",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Cholesterol",
        "Triglycerides",
        "HDL Cholesterol",
        "LDL Cholesterol"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, body mass index (BMI), duration of type 2 diabetes, glycosylated hemoglobin (HbA1c) at screening, fasting plasma glucose at screening, systolic blood pressure, diastolic blood pressure, heart rate, weight, oral antidiabetic drug (OAD) use, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Percentage of Glycosylated Hemoglobin (HbA1c)",
          "glycosylated hemoglobin (HbA1c) at screening"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Fasting Blood Glucose (FBG)"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "fasting plasma glucose at screening",
        "systolic blood pressure",
        "diastolic blood pressure",
        "heart rate",
        "weight",
        "oral antidiabetic drug (OAD) use",
        "smoking status."
      ]
    }
  }
}